### Comparison 1. Oral steroid versus placebo- short term <= 3 weeks

| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|:---|:---:|:---:|:---|:---|
| 1 FEV1 (ml) all studies | 14 | 687 | WMD (Fixed, 95% CI) | 53.30 [22.21, 84.39] |
| 1.1 High dose oral steroid | 13 | 667 | WMD (Fixed, 95% CI) | 54.19 [22.96, 85.43] |
| 1.2 Low dose oral steroid | 1 | 20 | WMD (Fixed, 95% CI) | -40.0 [-359.99, 279.99] |
| 2 FEV1 (ml)- sub-group results | 1 | | WMD (Fixed, 95% CI) | 50.39 [-0.60, 101.38] |
| 2.1 Lowest baseline sputum eosinophil count tertile | 1 | | WMD (Fixed, 95% CI) | -5.0 [-83.40, 73.40] |
| 2.2 Middle baseline sputum eosinophil count tertile | 1 | | WMD (Fixed, 95% CI) | 55.0 [-23.40, 133.40] |
| 2.3 Highest baseline sputum eosinophil count tertile | 1 | | WMD (Fixed, 95% CI) | 190.0 [60.00, 320.00] |
| 3 > 20% response to treatment in FEV1 | 10 | | OR (Fixed, 95% CI) | 2.71 [1.84, 4.01] |
| 3.1 High dose oral steroid | 10 | | OR (Fixed, 95% CI) | 2.71 [1.84, 4.01] |
| 4 Quality of life- overall score | 1 | | WMD (Fixed, 95% CI) | 0.32 [0.17, 0.47] |
| 4.1 High dose oral steroids | 1 | | WMD (Fixed, 95% CI) | 0.32 [0.17, 0.47] |
| 5 Quality of life- dyspnoea score (CRQ) | 3 | | WMD (Fixed, 95% CI) | 0.30 [-0.07, 0.67] |
| 5.1 High dose oral steroids (no ICS) | 1 | | WMD (Fixed, 95% CI) | 0.42 [-0.02, 0.86] |
| 5.2 Concurrent ICS use with high dose OS | 2 | | WMD (Fixed, 95% CI) | 0.01 [-0.66, 0.68] |
| 6 Quality of life- fatigue score (CRQ) | 3 | | WMD (Fixed, 95% CI) | 0.33 [0.12, 0.54] |
| 6.1 High dose oral steroids (no ICS) | 1 | | WMD (Fixed, 95% CI) | 0.36 [0.14, 0.58] |
| 6.2 Concurrent ICS use with high dose OS | 2 | | WMD (Fixed, 95% CI) | 0.06 [-0.61, 0.72] |
| 7 Quality of life- emotional function score (CRQ) | 3 | | WMD (Fixed, 95% CI) | 0.21 [0.06, 0.37] |
| 7.1 High dose oral steroids (no ICS) | 1 | | WMD (Fixed, 95% CI) | 0.13 [-0.03, 0.29] |
| 7.2 Concurrent ICS use with high dose OS | 2 | | WMD (Fixed, 95% CI) | 1.60 [0.93, 2.26] |
| 8 Quality of life- mastery score (CRQ) | 3 | | WMD (Fixed, 95% CI) | 0.17 [-0.02, 0.36] |
| 8.1 High dose oral steroids (no ICS) | 1 | | WMD (Fixed, 95% CI) | 0.23 [0.03, 0.43] |
| 8.2 Concurrent ICS use with high dose OS | 2 | | WMD (Fixed, 95% CI) | -0.28 [-0.82, 0.27] |
| 9 Quality of life- dyspnoea score (CRQ) by eosinophil tertile | 1 | | WMD (Random, 95% CI) | 0.42 [-0.02, 0.86] |
| 9.1 Lowest baseline sputum eosinophil count | 1 | | WMD (Random, 95% CI) | 0.15 [-0.05, 0.35] |
| 9.2 Middle baseline sputum eosinophil count | 1 | | WMD (Random, 95% CI) | 0.27 [-0.11, 0.65] |
| 9.3 Highest baseline sputum eosinophil count | 1 | | WMD (Random, 95% CI) | 0.93 [0.51, 1.35] |
| 10 Quality of life- fatigue score (CRQ) by eosinophil tertile | 1 | | WMD (Fixed, 95% CI) | 0.36 [0.14, 0.58] |
| 10.1 Lowest baseline sputum eosinophil count | 1 | | WMD (Fixed, 95% CI) | 0.09 [-0.28, 0.46] |
| 10.2 Middle baseline sputum eosinophil count | 1 | | WMD (Fixed, 95% CI) | 0.42 [-0.00, 0.84] |
| 10.3 Highest baseline sputum eosinophil count | 1 | | WMD (Fixed, 95% CI) | 0.56 [0.21, 0.91] |
| 11 Quality of life- emotional function score (CRQ) by eosinophil tertile | 1 | | WMD (Fixed, 95% CI) | 0.13 [-0.03, 0.29] |
| 11.1 Lowest baseline sputum eosinophil count | 1 | | WMD (Fixed, 95% CI) | 0.08 [-0.18, 0.34] |
| 11.2 Middle baseline sputum eosinophil count | 1 | | WMD (Fixed, 95% CI) | 0.12 [-0.15, 0.39] |
| 11.3 Highest baseline sputum eosinophil count | 1 | | WMD (Fixed, 95% CI) | 0.19 [-0.11, 0.49] |

<PAGE>125